Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Q1:18 Hospital Deals Rise 25% YoY

Q1:18 Hospital Deals Rise 25% YoY

Mergers and acquisitions in the Hospital sector picked up slightly in the first quarter, up 9% compared with the previous one to 25 deals. It was up 25% compared with the same quarter in 2017, and the 25 deals comprise 29% of the 86 deals announced in the previous 12 months. Some of the activity is still being fueled by divestitures by the publicly traded companies, Community Health Systems (NYSE: CYH), Quorum Health (NYSE: QHC), and Tenet Healthcare (NYSE: THC). All are trying to lower their debt load, and for Community Health and Tenet, activist shareholders are demanding more attention to the balance sheet. In the first quarter, Community Health sold five hospitals (one in Louisiana,... Read More »
Welltower and ProMedica Buy QCP and HCRMC

Welltower and ProMedica Buy QCP and HCRMC

Toledo, Ohio is a hotbed of healthcare deal making, all of a sudden. Three companies based there joined together to carve up HCR ManorCare, the financially beleauered tenant of Toledo-based Quality Care Properties, Inc. (NYSE: QCP). Welltower Inc. (NYSE: WELL) and not-for-profit ProMedica Health System joined the fray, and it became one complicated deal. Quality Care Properties was spun out from HCP, Inc. in October 2016, taking with it HCP’s skilled nuring assets, most of which were operated by HCR ManorCare (HCRMC). As of December 31, 2017, QCP owned 259 skilled nursing facilities with 22,205 beds, 59 assisted living/memory care communities with 3,843 units, one 37-bed surgical... Read More »
Health Care M&A Weekly Deals, The Week Ending April 27, 2018

Health Care M&A Weekly Deals, The Week Ending April 27, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.   Behavioral Health Care Acquirer Target Price Delphi Behavioral Health Group Summit Behavioral Healthcare LLC Merger Riverside Community Care Screening For Mental Health Merger Biotechnology Acquirer Target Price Zai Lab Limited... Read More »
Q1:18 Health Care Spending: $112.9 Billion

Q1:18 Health Care Spending: $112.9 Billion

A total of $112.9 billion was spent to fund the 386 transactions reported in Q1:18, based on disclosed prices. Total spending was about 2% lower than the $115.1 billion reported in the previous quarter. The Other Services sector dominated the dollar side of deal making, accounting for 60% ($68.2 billion) of spending. A single deal accounted for 59% of the quarter’s total, as Cigna (NYSE: CI) announced its acquisition of Express Scripts Holdings (NYSE: ESRX) for $67 billion, including debt. Source: HealthCareMandA.com, April 2018 The Biotechnology sector made up 28% ($31.2 billion) of spending in the first quarter. Many of the deals were front-loaded into January, so their announcements... Read More »
Health Care M&A Weekly Deals, The Week Ending April 27, 2018

Health Care M&A Weekly Deals, The Week Ending April 20, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care     Acquirer Target Price Center for Discovery Cliffside Malibu Merger       Biotechnology     Acquirer Target Price Basilea Pharmaceutica International Limited Exclusive license to... Read More »
Home Health & Hospice Deals Up 50% in Q1:18

Home Health & Hospice Deals Up 50% in Q1:18

After three straight quarters of relatively low home health and hospice merger and acquisition activity, the first quarter of 2018 saw 21 publicly announced transactions. This was a 50% increase from the fourth quarter of 2017 (14 transactions), but just a 5% increase from the year-ago quarter (20 transactions), according to new data from HealthCareMandA.com. Only three of the 21 transactions in this year’s first quarter disclosed a price, and the total was a small $46.1 million. This was similar to last year’s first quarter total of $20.9 million, but not comparable to last year’s fourth quarter when nearly $4.1 billion was announced encompassing just two acquisitions. During the first... Read More »
Physician Medical Group Deals Stayed Strong in Q1:18

Physician Medical Group Deals Stayed Strong in Q1:18

Physician medical group M&A activity was strong in the first quarter of 2018, according to new acquisition data from HealthCareMandA.com. The number of physician medical group acquisitions increased to 36 in the first quarter, up 9% from the 33 publicly announced acquisitions in the fourth quarter of 2017. Compared with the year-earlier quarter, when a recent record of 59 deals were reported, deal activity was down 39%. None of the transactions disclosed a purchase price. The most prolific buyers were MEDNAX, Inc. (NYSE: MD) and Eye Health South with three acquisitions each, followed by Anne Arundel Dermatology, Gauge Capital, Platinum Dermatology and Team Health, with two deals each.... Read More »
Takeda Takes Aim at Shire

Takeda Takes Aim at Shire

Big Pharma deals are making a comeback. Or so it seems from the speculation around Shire plc (NASDAQ: SHPG). Japanese drug maker Takeda Pharmaceutical Co. (OTCQB: TKPYY) has been buzzing around the UK-based Shire for nearly a month, making bid after bid. It seemed to begin on April 16, when Shire sold its oncology business to the French drug maker Servier, for $2.4 billion in cash. In 2017, the 0ncology business generated revenues of $262 million. The total consideration represents a revenue multiple of 9.2x 2017 revenues. The acquisition gives Servier a direct commercial presence in the United States and boosts its presence in cancer. Servier’s products will be commercialized in the... Read More »
Q1:18 Health Care Spending: $112.9 Billion

Q1:18 Health Care M&A Stays Strong

Health care merger and acquisition activity in the first quarter of 2018 kept pace with the previous quarter in 2017. Compared with the fourth quarter of 2017, deal volume increased 1%, to 386 transactions. However, deal volume was down 12% compared with the same quarter the year before. Combined spending in the first quarter reached $112.9 billion, a decrease of 2% compared with the nearly $115.0 billion spent in the previous quarter, according to HealthCareMandA.com. Thanks to the announcement of a multi-billion-dollar deal in Q1:18, deal value rose 90% compared with $59.6 billion spent in Q1:17. Health Care M&A Market – Deal Volume by Sector Source: HealthCareMandA,com, April 2018... Read More »
Health Care M&A Weekly Deals, The Week Ending April 27, 2018

Health Care M&A Weekly Deals, The Week Ending April 13, 2018

We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Summit BHC Cottonwood Tucson N/A Biotechnology Acquirer Target Price Alexion Pharmaceuticals, Inc. Wilson Therapeutics AB $855 million Promethera Biosciences Baliopharm AG N/A Novartis AG AveXis... Read More »